Govindan R - Search Results

1

PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.

Zinner RG, Obasaju CK, Spigel DR, Weaver RW, Beck JT, Waterhouse DM, Modiano MR, Hrinczenko B, Nikolinakos PG, Liu J, Koustenis AG, Winfree KB, Melemed SA, Guba SC, Ortuzar WI, Desaiah D, Treat JA, Govindan R, Ross HJ. Zinner RG, et al. Among authors: govindan r. J Thorac Oncol. 2015 Jan;10(1):134-42. doi: 10.1097/JTO.0000000000000366. J Thorac Oncol. 2015. PMID: 25371077 Free PMC article. Clinical Trial.

2

Practical issues in the management of the patient with small cell lung cancer.

Govindan R, Ihde DC. Govindan R, et al. Chest Surg Clin N Am. 1997 Feb;7(1):167-81. Chest Surg Clin N Am. 1997. PMID: 9001763 Review.

3

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.

Arquette M, Wasserman T, Govindan R, Garfield D, Senzer N, Gillenwater H, Socinski M. Arquette M, et al. Among authors: govindan r. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):59-61. doi: 10.1053/srao.2002.31375. Semin Radiat Oncol. 2002. PMID: 11917286 Clinical Trial.

4

Management of patients with non-small cell lung cancer and poor performance status.

Govindan R. Govindan R. Curr Treat Options Oncol. 2003 Feb;4(1):55-9. doi: 10.1007/s11864-003-0031-x. Curr Treat Options Oncol. 2003. PMID: 12525279 Review.

5

Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.

Fracasso PM, Rodriguez LC, Herzog TJ, Fears CL, Goodner SA, Govindan R, Picus J, Rader JS, Tan BR, Arquette MA. Fracasso PM, et al. Among authors: govindan r. Cancer. 2003 Aug 1;98(3):610-7. doi: 10.1002/cncr.11547. Cancer. 2003. PMID: 12879480 Free article. Clinical Trial.

6

Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancer.

Govindan R, Read W, Faust J, Mc Leod H. Govindan R, et al. Oncology (Williston Park). 2003 Jul;17(7 Suppl 7):27-9. Oncology (Williston Park). 2003. PMID: 12886871 Clinical Trial.

7

Cetuximab in advanced non-small cell lung cancer.

Govindan R. Govindan R. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4241s-4244s. doi: 10.1158/1078-0432.CCR-040015. Clin Cancer Res. 2004. PMID: 15217966 Review.

8

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.

Kommareddy A, Coplin MA, Gao F, Behnken D, Romvari E, Read W, Govindan R. Kommareddy A, et al. Among authors: govindan r. Lung Cancer. 2004 Aug;45(2):221-5. doi: 10.1016/j.lungcan.2004.01.022. Lung Cancer. 2004. PMID: 15246194

9

Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status.

Govindan R, Garfield DH. Govindan R, et al. Semin Oncol. 2004 Dec;31(6 Suppl 11):27-31. doi: 10.1053/j.seminoncol.2004.10.006. Semin Oncol. 2004. PMID: 15599832 Review.

10

Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.

Govindan R, Kratzke RA, Herndon JE 2nd, Niehans GA, Vollmer R, Watson D, Green MR, Kindler HL; Cancer and Leukemia Group B (CALGB 30101). Govindan R, et al. Clin Cancer Res. 2005 Mar 15;11(6):2300-4. doi: 10.1158/1078-0432.CCR-04-1940. Clin Cancer Res. 2005. PMID: 15788680 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

628 results

Search Page